CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma (Q39575135)

13 September 2017

CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma (English)

1 reference

13 September 2017

19

Zora Modrusan

1 reference

13 September 2017

4

Ranjana Advani

1 reference

13 September 2017

Bart Burington

1

1 reference

13 September 2017

Peng Yue

2

1 reference

13 September 2017

Xiaoyan Shi

3

1 reference

13 September 2017

Jeffrey T Lau

5

1 reference

13 September 2017

Jenille Tan

6

1 reference

13 September 2017

Susanna Stinson

7

1 reference

13 September 2017

Jeremy Stinson

8

1 reference

13 September 2017

Thomas Januario

9

1 reference

13 September 2017

Sven de Vos

10

1 reference

13 September 2017

Stephen Ansell

11

1 reference

13 September 2017

Andres Forero-Torres

12

1 reference

13 September 2017

Grazyna Fedorowicz

13

1 reference

13 September 2017

Teddy T C Yang

14

1 reference

13 September 2017

Kristi Elkins

15

1 reference

13 September 2017

Changchun Du

16

1 reference

13 September 2017

Sankar Mohan

17

1 reference

13 September 2017

Nancy Yu

18

1 reference

13 September 2017

Somasekar Seshagiri

20

1 reference

13 September 2017

Shang-Fan Yu

21

1 reference

13 September 2017

Ajay Pandita

22

1 reference

13 September 2017

Hartmut Koeppen

23

1 reference

13 September 2017

Dorothy French

24

1 reference

13 September 2017

Andrew G Polson

25

1 reference

13 September 2017

Rienk Offringa

26

1 reference

13 September 2017

Nancy Whiting

27

1 reference

13 September 2017

Allen Ebens

28

1 reference

13 September 2017

David Dornan

29

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Science Translational Medicine

13 September 2017

1 reference

13 September 2017

3

1 reference

13 September 2017

74

1 reference

13 September 2017

74ra22

1 reference

Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells

13 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Proliferation of precursor B-lineage acute lymphoblastic leukaemia by activating the CD40 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Germinal centres: role in B-cell physiology and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Tracking CD40 signaling during germinal center development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

The duration of fixation influences the yield of HCV cDNA-PCR products from formalin-fixed, paraffin-embedded liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Microarray analysis of RNA extracted from formalin-fixed, paraffin-embedded and matched fresh-frozen ovarian adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001620

10.1126/SCITRANSLMED.3001620

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference